Efficacy of SCH27899 in an animal model of legionnaires' disease using immunocompromised A/J mice

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 5, 2000, Pages 1333-1336

  Brieland, Joan K ^a   Loebenberg, David ^a   Menzel, Fred ^a   Hare, Roberta S ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; EVERNIMICIN; EVERNINOMICIN; OFLOXACIN;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIOSTASIS; CONTROLLED STUDY; FEMALE; IMMUNE DEFICIENCY; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINOGLYCOSIDES; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZITHROMYCIN; CORTISONE; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOCOMPROMISED HOST; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; LUNG; MICE; OFLOXACIN;

EID: 0034090834     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.5.1333-1336.2000     Document Type: Article

References (13)

1. Brieland, J., P. Freeman, R. Kunkel, C. Chrisp, M. Hurley, J. Fantone, and C. Engleberg. 1994. Replicative Legionella pneumophila lung infection in intratracheally inoculated A/J mice. A murine model of human Legionnaires' disease. Am. J. Pathol. 145:1537-1546.
2. Chow, J. W., and V. L. Yu. 1998. Legionella: a major opportunistic pathogen in transplant recipients. Semin. Respir. Infect. 13:132-139.
3. Edelstein, P. H. 1981. Improved semiselective medium for isolation of Legionella pneumophila from contaminated clinical and environmental specimens. J. Clin. Microbiol. 14:298-303.
4. Edelstein, P. H., and M. A. C. Edelstein. 1999. In vitro activity of SCH 27899 (Ziracin) against 104 Legionella species. Diagn. Microbiol. Infect. Dis. 33: 59-62.
5. Feeley, J. C., R. J. Gibson, G. W. Gorman, N. C. Langford, J. K. Raheed, D. C. Mackel, and W. B. Baine. 1979. Charcoal-yeast extract agar: primary medium for Legionella pneumophila. J. Clin. Microbiol. 10:437-441.
6. Harrington, R. D., A. E. Woolfrey, R. Bowden, M. G. McDowell, and R. C. Hackman. 1996. Legionellosis in a bone marrow transplant center. Bone Marrow Transplant. 18:361-368.
7. Horwitz, M. A. 1984. Phagocytosis of Legionnaires' disease bacterium (Legionella pneumophila) multiplies intracellularly in human monocytes. J. Clin. Investig. 66:441-450.
8. Lode, H., K. Borner, P. Koeppe, and T. Schaberg. 1996. Azithromycin - review of key chemical, pharmacokinetic and microbiological features. J. Antimicrob. Chemother. 37(Suppl. C):1-8.
9. McDade, J. E., C. C. Shepard, D. W. Fraser, T. R. Tsai, M. A. Redus, and W. R. Dowdle. 1977. Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N. Engl. J. Med. 297:1197-1203.
10. Nash, T. W., D. M. Libby, and M. A. Horwitz. 1984. Interaction between Legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines and hydrocortisone. J. Clin. Investig. 74:771-782.
11. 10a. National Research Council. 1996. NIH guide to the care and use of laboratory animals. National Academy Press, Washington, D.C.
12. Schlossberg, D., and J. Bonan. 1998. Legionella and immunosuppression. Semin. Respir. Infect. 13:128-131.
13. Stein-Streilein, J., and J. Guffee. 1986. In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J. Immunol. 136:1435-1441.